| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0891-5520(05)70255-5 |
| P698 | PubMed publication ID | 10829263 |
| P2093 | author name string | Bush LM | |
| Johnson CC | |||
| P2860 | cites work | Efficacy, safety and tolerance of parenteral piperacillin/tazobactam in the treatment of patients with lower respiratory tract infections | Q72956661 |
| Antibiotics in penetrating abdominal trauma. Comparison of ticarcillin plus clavulanic acid with gentamicin plus clindamycin | Q93655604 | ||
| Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus | Q24600383 | ||
| Beta-lactamase inhibitors from laboratory to clinic | Q24617277 | ||
| In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates | Q24681289 | ||
| An open, comparative study of sulbactam plus ampicillin vs. cefotaxime as initial therapy for serious soft tissue and bone and joint infections | Q28287908 | ||
| Amoxicillin-clavulanic acid for treating drug-resistant Mycobacterium tuberculosis | Q28333284 | ||
| In vitro activity of amoxicillin in combination with clavulanic acid against Mycobacterium tuberculosis | Q28366594 | ||
| Multiple changes of penicillin-binding proteins in penicillin-resistant clinical isolates of Streptococcus pneumoniae | Q33724965 | ||
| In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains | Q33728203 | ||
| Mezlocillin for treatment of infections in cancer patients | Q33730391 | ||
| Comparative bactericidal effects of azlocillin and ticarcillin against Pseudomonas aeruginosa | Q33731600 | ||
| Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients | Q33731809 | ||
| Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance study | Q33977347 | ||
| The role of the bacterial cell envelope in antibiotic resistance | Q34079929 | ||
| Susceptibility of the Anaerobic Bacteria, Group D Streptococci, Enterobacteriaceae , and Pseudomonas to Semisynthetic Penicillins: Carbenicillin, Piperacillin, and Ticarcillin | Q34503672 | ||
| Microbial resistance to newer generation beta-lactam antibiotics: clinical and laboratory implications | Q34563999 | ||
| Activity of newer beta-lactam agents against clinical isolates of Bacteroides fragilis and other Bacteroides species | Q35563175 | ||
| Comparison of the activities of penicillin G and new beta-lactam antibiotics against clinical isolates of Bacteroides species | Q35568428 | ||
| Clinical trial of the efficacy and safety of ticarcillin and clavulanic acid. | Q35570220 | ||
| In vitro activity of aminopenicillins combined with sulbactam, clavulanic acid, or amdinocillin against bacteria isolated from patients with complicated urinary tract infections | Q43900292 | ||
| Treatment of ventilator-associated pneumonia with piperacillin-tazobactam/amikacin versus ceftazidime/amikacin: a multicenter, randomized controlled trial. VAP Study Group | Q44145974 | ||
| Piperacillin v Carbenicillin in the Therapy for Serious Infections | Q44207212 | ||
| Treatment of patients with acute recurrent tonsillitis due to group A beta-haemolytic streptococci: a prospective randomized study comparing penicillin and amoxycillin/clavulanate potassium | Q44316856 | ||
| Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center | Q44685672 | ||
| Pharmacology of ticarcillin combined with clavulanic acid in humans | Q44964984 | ||
| Clinical pharmacology and safety evaluation of Timentin | Q45277260 | ||
| Mezlocillin and carbenicillin: a clinical comparison of serious systemic infections in surgical patients. | Q53438413 | ||
| Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin for the treatment of patients with nosocomial lower respiratory tract infection. Piperacillin/tazobactam Nosocomial Pneumonia Study Group. | Q53933158 | ||
| Interactions of tazobactam and clavulanate with inducibly- and constitutively-expressed Class I beta-lactamases. | Q54331490 | ||
| The in-vitro activity of mezlocillin against community hospital isolates in comparison to other penicillins and cephalosporins. | Q54498017 | ||
| Resistance to Cefamandole: A Collaborative Study of Emerging Clinical Problems | Q54526297 | ||
| Piperacillin therapy for serious bacterial infections. | Q54549903 | ||
| Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection. | Q54774005 | ||
| From Penicillin-Binding Proteins to the Lysis and Death of Bacteria: A 1979 View | Q57077311 | ||
| Single-dose pharmacokinetics of piperacillin and tazobactam in patients with renal disease | Q67485735 | ||
| A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity | Q67900697 | ||
| Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics | Q68807854 | ||
| Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strains | Q69364580 | ||
| Combinations of antibiotics against Pseudomonas aeruginosa | Q69958018 | ||
| Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonads | Q70148102 | ||
| A randomized, double-blind comparison of sulbactam/ampicillin and clindamycin for the treatment of aerobic and aerobic-anaerobic infections | Q70159391 | ||
| Ampicillin/sulbactam versus metronidazole-gentamicin in the treatment of soft tissue pelvic infections | Q70168563 | ||
| Combination effect of piperacillin with four aminoglycosides on nonfermenting gram-negative bacteria | Q70543285 | ||
| Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe | Q71722506 | ||
| In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin | Q72081206 | ||
| Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactam | Q72570609 | ||
| Piperacillin/tazobactam compared with ticarcillin/clavulanate in community-acquired bacterial lower respiratory tract infection | Q72574046 | ||
| Bacteriological antagonism between acylureidopenicillins and cephalosporins | Q72754316 | ||
| Safety profile of piperacillin/tazobactam in phase I and III clinical studies | Q72956643 | ||
| Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States | Q35572543 | ||
| Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients | Q35573306 | ||
| Comparative study of amoxicillin-clavulanic acid and cephalexin in the treatment of bacteriuria during pregnancy | Q35642260 | ||
| beta-Lactam-resistant Pseudomonas aeruginosa with modified penicillin-binding proteins emerging during cystic fibrosis treatment | Q35669515 | ||
| Comparison of the effects of mezlocillin, carbenicillin, and placebo on normal hemostasis | Q35756684 | ||
| Efficacy of ampicillin-sulbactam versus that of cefoxitin for treatment of Escherichia coli infections in a rat intra-abdominal abscess model | Q35810773 | ||
| Antimicrobial prophylaxis for major head and neck surgery in cancer patients: sulbactam-ampicillin versus clindamycin-amikacin | Q35900541 | ||
| Outpatient therapy of bite wounds. Demographic data, bacteriology, and a prospective, randomized trial of amoxicillin/clavulanic acid versus penicillin +/- dicloxacillin | Q36431754 | ||
| Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections | Q36758337 | ||
| Characterization of beta-lactamases | Q38640000 | ||
| Piperacillin, a new penicillin with high anti-pseudomonal activity | Q39200846 | ||
| The mechanism of the irreversible antimicrobial effects of penicillins: how the beta-lactam antibiotics kill and lyse bacteria | Q39279622 | ||
| Comparative Study of Anti-Pseudomonas Activity of Azlocillin, Mezlocillin, and Ticarcillin | Q39675318 | ||
| Comparative In Vitro Activity of Azlocillin, Ampicillin, Mezlocillin, Piperacillin, and Ticarcillin, Alone and in Combination with an Aminoglycoside | Q39675343 | ||
| Evaluation of piperacillin-tazobactam in experimental meningitis caused by a beta-lactamase-producing strain of K1-positive Escherichia coli | Q39815796 | ||
| Antibacterial characteristics of YTR 830, a sulfone beta-lactamase inhibitor, compared with those of clavulanic acid and sulbactam | Q39818370 | ||
| Early synergistic interactions between amikacin and six beta-lactam antibiotics against multiply resistant members of the family Enterobacteriaceae | Q39833523 | ||
| Imipenem-induced resistance to antipseudomonal beta-lactams in Pseudomonas aeruginosa | Q39834069 | ||
| Resistance of Pseudomonas aeruginosa to new beta-lactamase-resistant beta-lactams | Q39849040 | ||
| Resistance caused by decreased penetration of beta-lactam antibiotics into Enterobacter cloacae | Q39849656 | ||
| In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria | Q39849981 | ||
| Effects of sodium piperacillin on platelet function in normal volunteers | Q39854806 | ||
| In vitro and in vivo antibacterial effects of combinations of beta-lactam antibiotics | Q39854912 | ||
| Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens | Q39855592 | ||
| Comparative activity of mezlocillin, penicillin, ampicillin, carbenicillin, and ticarcillin against gram-positive bacteria and Haemophilus influenzae | Q39856244 | ||
| Kinetic interactions of tazobactam with beta-lactamases from all major structural classes | Q39865634 | ||
| The beta-lactamases of gram-negative bacteria and their possible physiological role. | Q39930404 | ||
| Onset of penicillin-induced bacteriolysis in staphylococci is cell cycle dependent | Q39948722 | ||
| Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins | Q40113603 | ||
| Penicillin-binding proteins and the mechanism of action of beta-lactam antibiotics | Q40157128 | ||
| Review of the pharmacokinetics and dose dependency of azlocillin in normal subjects and patients with renal insufficiency | Q40158223 | ||
| The Acylampicillins: Mezlocillin, Piperacillin, and Azlocillin | Q40173629 | ||
| Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important beta-lactamases | Q40285545 | ||
| The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics | Q40576484 | ||
| Azlocillin and mezlocillin: new ureido penicillins | Q40618649 | ||
| Combined Activity of Clavulanic Acid and Ticarcillin Against Ticarcillin-Resistant, Gram-Negative Bacilli | Q40618972 | ||
| Clavulanic Acid, a Novel Inhibitor of β-Lactamases | Q40619414 | ||
| Comparison of the Activities of the New Ureidopenicillins Piperacillin, Mezlocillin, Azlocillin, and Bay k 4999 Against Gram-Negative Organisms | Q40620769 | ||
| Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients. | Q40723790 | ||
| Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer | Q40782522 | ||
| Empirical antimicrobial therapy with Timentin plus amikacin in febrile granulocytopenic cancer patients | Q40808429 | ||
| A controlled study of ticarcillin plus clavulanic acid versus piperacillin as empiric therapy for fever in the immunocompromised host | Q40813799 | ||
| Susceptibility of anaerobic bacteria to beta-lactam antibiotics in the United States | Q40822097 | ||
| Piperacillin Plus Amikacin Therapy v Carbenicillin Plus Amikacin Therapy in Febrile, Granulocytopenic Patients | Q40842641 | ||
| Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients | Q40849659 | ||
| Mezlocillin in the therapy of serious infections | Q41828669 | ||
| Penetration of sulbactam and ampicillin into peritoneal fluid | Q42030800 | ||
| Safety and efficacy of ticarcillin plus clavulanic acid in the treatment of infections of soft tissue, bone, and joint | Q43427224 | ||
| Ticarcillin plus clavulanic acid versus cefoxitin in the prophylaxis of infection after cesarean section | Q43499495 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 409-33, ix | |
| P577 | publication date | 2000-06-01 | |
| P1433 | published in | Infectious Disease Clinics of North America | Q15754797 |
| P1476 | title | Ureidopenicillins and beta-lactam/beta-lactamase inhibitor combinations | |
| P478 | volume | 14 |
| Q37973385 | Adverse reactions to β-lactam antimicrobials |
| Q41437396 | Comparative Evaluation of the in-vitro Activity of Six β-lactam/β-lactamase Inhibitor Combinations against Gram Negative Bacilli |
| Q37423606 | Design, synthesis and microbiological evaluation of ampicillin-tetramic acid hybrid antibiotics |
| Q33972291 | Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase |
| Q34262986 | History of antibiotics. From salvarsan to cephalosporins |
| Q57789710 | Impacts of L1 Promoter Variation and L2 Clavulanate Susceptibility on Ticarcillin-Clavulanate Susceptibility of Stenotrophomonas maltophilia |
| Q42339300 | Sensitivity of levofloxacin in combination with ampicillin-sulbactam and tigecycline against multidrug-resistant Acinetobacter baumannii |
| Q40366089 | Synthesis, spectral and extended spectrum beta-lactamase studies of transition metal tetraaza macrocyclic complexes. |
| Q53782264 | The effects of amoxicillin with or without clavulanic acid on the postoperative complaints after third molar surgery: a retrospective chart analysis. |
| Q24646623 | Three decades of beta-lactamase inhibitors |
| Q91647786 | [Three keys to the appropriate choice of oral antibiotic treatment in the respiratory tract infections] |
Search more.